Health & Environmental Research Online (HERO)


Print Feedback Export to File
7417070 
Journal Article 
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns 
Kirby, MK; Ramaker, RC; Roberts, BS; Lasseigne, BN; Gunther, DS; Burwell, TC; Davis, NS; Gulzar, ZG; Absher, DM; Cooper, SJ; Brooks, JD; Myers, RM; , 
2017 
Yes 
BMC Cancer
ISSN: 1471-2407
EISSN: 14712407 
BMC 
LONDON 
English 
28412973 
WOS:000399668700002 
Current diagnostic tools for prostate cancer lack specificity and sensitivity for detecting very early lesions. DNA methylation is a stable genomic modification that is detectable in peripheral patient fluids such as urine and blood plasma that could serve as a non-invasive diagnostic biomarker for prostate cancer.